Literature DB >> 24222944

Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.

Meng Li1, Zhe Shen, You-Ming Li.   

Abstract

Accumulating evidence has implicated Helicobacter pylori (H. pylori) infection in extragastrointestinal diseases, including obesity, type 2 diabetes mellitus, cardiovascular disease, and liver disease. Recently, there has been a special focus on H. pylori infection as a risk factor for the development of nonalcoholic fatty liver disease (NAFLD). NAFLD is currently considered to be the most common liver disorder in western countries, and is rapidly becoming a serious threat to public health. The mechanisms of pathogenesis underlying NAFLD remain unclear at present and therapeutic options are limited. The growing awareness of the role of H. pylori in NAFLD is thus important to aid the development of novel intervention and prevention strategies, because the eradication of H. pylori is easy and much less expensive than long-term treatment of the other risk factors. H. pylori infection is involved in the pathogenesis of insulin resistance (IR), which is closely linked with NAFLD. It provides a new insight into the pathogenesis of NAFLD. This review probes the possible relationship between H. pylori and NAFLD, from the perspective of the potential mechanism of how H. pylori infection brings about IR and other aspects concerning this correlation.

Entities:  

Keywords:  Cytokines; Helicobacter pylori; Inflammation; Insulin resistance; Nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2013        PMID: 24222944      PMCID: PMC3819536          DOI: 10.3748/wjg.v19.i41.7024

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  101 in total

1.  Rapid molecular identification and subtyping of Helicobacter pylori by pyrosequencing of the 16S rDNA variable V1 and V3 regions.

Authors:  H Monstein; S Nikpour-Badr; J Jonasson
Journal:  FEMS Microbiol Lett       Date:  2001-05-15       Impact factor: 2.742

Review 2.  Insulin resistance--mechanisms, syndromes, and implications.

Authors:  D E Moller; J S Flier
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

3.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

4.  Celiac disease, primary biliary cirrhosis and helicobacter pylori infection: one link for three diseases.

Authors:  L Abenavoli; V Arena; F Giancotti; F M Vecchio; S Abenavoli
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

Review 5.  Diabetes and cardiovascular disease. The "common soil" hypothesis.

Authors:  M P Stern
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

6.  Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases.

Authors:  Mehmet Cindoruk; Meltem Yalinay Cirak; Selahattin Unal; Tarkan Karakan; Gulbanu Erkan; Doruk Engin; Sukru Dumlu; Sevgi Turet
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-01       Impact factor: 2.566

7.  Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

Authors:  R Feinstein; H Kanety; M Z Papa; B Lunenfeld; A Karasik
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

8.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

Review 9.  Epidemiology and natural history of patients with NAFLD.

Authors:  Neeraj Bhala; Ramy Younes; Elisabetta Bugianesi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

View more
  20 in total

Review 1.  The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease.

Authors:  Derek M Tang; Sheila Kumar
Journal:  Curr Gastroenterol Rep       Date:  2017-02

2.  Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.

Authors:  Yoshio Sumida; Kazuyuki Kanemasa; Shunsuke Imai; Kojiro Mori; Saiyu Tanaka; Hideto Shimokobe; Yoko Kitamura; Kohei Fukumoto; Akira Kakutani; Tomoyuki Ohno; Hiroyoshi Taketani; Yuya Seko; Hiroshi Ishiba; Tasuku Hara; Akira Okajima; Kanji Yamaguchi; Michihisa Moriguchi; Hironori Mitsuyoshi; Kohichiroh Yasui; Masahito Minami; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2015-01-28       Impact factor: 7.527

Review 3.  Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Shao-Ren Zhang; Xiao-Ming Fan
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

4.  A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.

Authors:  Tae Jun Kim; Dong Hyun Sinn; Yang Won Min; Hee Jung Son; Jae J Kim; Yoosoo Chang; Sun-Young Baek; Soo Hyun Ahn; Hyuk Lee; Seungho Ryu
Journal:  J Gastroenterol       Date:  2017-04-05       Impact factor: 7.527

Review 5.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

Review 6.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

7.  Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.

Authors:  Myong Ki Baeg; Seung Kew Yoon; Sun-Hye Ko; Yong-Sun Noh; In-Seok Lee; Myung-Gyu Choi
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 8.  Is Helicobacter pylori infection associated with glycemic control in diabetics?

Authors:  Yi-Ning Dai; Wei-Lai Yu; Hua-Tuo Zhu; Jie-Xia Ding; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

9.  H. pylori is related to NAFLD but only in female: A Cross-sectional Study.

Authors:  Jingwei Wang; Fengxiao Dong; Hui Su; Licun Zhu; Sujun Shao; Jing Wu; Hong Liu
Journal:  Int J Med Sci       Date:  2021-04-02       Impact factor: 3.738

10.  Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.

Authors:  Christian S Alvarez; Andrea A Florio; Julia Butt; Alvaro Rivera-Andrade; María F Kroker-Lobos; Tim Waterboer; Maria Constanza Camargo; Neal D Freedman; Barry I Graubard; Mariana Lazo; Eliseo Guallar; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn
Journal:  Helicobacter       Date:  2020-10-02       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.